Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation

V. Rettori, Alejandro Lomniczi, J. C. Elverdin, A. Suburo, A. Faletti, A. Franchi, S. M. McCann

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In many in vivo systems exposure to endotoxins (LPS) leads to the co-induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which is important to the regulation of the function of different systems during infection. In submandibular glands (SMG) neural (n)NOS is localized in neural terminals and in striated, granular convoluted and excretory ducts, endothelial (e)NOS in vascular endothelium and ducts, and iNOS in macrophages and in tubules and ducts. In normal adult male rats, injection of an inhibitor of NOS decreased the stimulated salivary secretion and a donor of NO potentiated it, indicating that NO exerts a stimulatory role. A single high dose of LPS (5 mg/kg, i.p.) induced an increase in NOS activity measured by the 14C-citrulline method, increased PGE content almost 100% as measured by RIA, and blocked stimulated salivary secretion. The administration of a specific iNOS inhibitor, aminoguanidine (AG), with LPS not only decreased NOS activity but significantly decreased PGE content, indicating that NO triggered the activation of COX-2. LPS increased conversion of labeled arachidonate to prostaglandins (PGs) showing that COX was induced. Since a PGE1 analogue blocked stimulated salivation, the LPS-induced inhibition of salivation is probably due to release of PGs. Therefore, the use of inhibitors of iNOS and COX-2 could be very useful to increase salivation during infection since saliva has antimicrobial actions.

Original languageEnglish (US)
Pages (from-to)258-267
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume917
StatePublished - 2000
Externally publishedYes

Fingerprint

Neuroimmunomodulation
Nitric Oxide Synthase Type II
Salivation
Nitric Oxide
Cyclooxygenase 2
Ducts
Prostaglandins E
Prostaglandins
Citrulline
Macrophages
Submandibular Gland
Alprostadil
Vascular Endothelium
Infection
Saliva
Endotoxins
Rats
Chemical activation
Injections
Secretion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Rettori, V., Lomniczi, A., Elverdin, J. C., Suburo, A., Faletti, A., Franchi, A., & McCann, S. M. (2000). Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation. Annals of the New York Academy of Sciences, 917, 258-267.

Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation. / Rettori, V.; Lomniczi, Alejandro; Elverdin, J. C.; Suburo, A.; Faletti, A.; Franchi, A.; McCann, S. M.

In: Annals of the New York Academy of Sciences, Vol. 917, 2000, p. 258-267.

Research output: Contribution to journalArticle

Rettori, V, Lomniczi, A, Elverdin, JC, Suburo, A, Faletti, A, Franchi, A & McCann, SM 2000, 'Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation', Annals of the New York Academy of Sciences, vol. 917, pp. 258-267.
Rettori, V. ; Lomniczi, Alejandro ; Elverdin, J. C. ; Suburo, A. ; Faletti, A. ; Franchi, A. ; McCann, S. M. / Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation. In: Annals of the New York Academy of Sciences. 2000 ; Vol. 917. pp. 258-267.
@article{208b810efcfd49ca8e561ef0632abc5b,
title = "Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation",
abstract = "In many in vivo systems exposure to endotoxins (LPS) leads to the co-induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which is important to the regulation of the function of different systems during infection. In submandibular glands (SMG) neural (n)NOS is localized in neural terminals and in striated, granular convoluted and excretory ducts, endothelial (e)NOS in vascular endothelium and ducts, and iNOS in macrophages and in tubules and ducts. In normal adult male rats, injection of an inhibitor of NOS decreased the stimulated salivary secretion and a donor of NO potentiated it, indicating that NO exerts a stimulatory role. A single high dose of LPS (5 mg/kg, i.p.) induced an increase in NOS activity measured by the 14C-citrulline method, increased PGE content almost 100{\%} as measured by RIA, and blocked stimulated salivary secretion. The administration of a specific iNOS inhibitor, aminoguanidine (AG), with LPS not only decreased NOS activity but significantly decreased PGE content, indicating that NO triggered the activation of COX-2. LPS increased conversion of labeled arachidonate to prostaglandins (PGs) showing that COX was induced. Since a PGE1 analogue blocked stimulated salivation, the LPS-induced inhibition of salivation is probably due to release of PGs. Therefore, the use of inhibitors of iNOS and COX-2 could be very useful to increase salivation during infection since saliva has antimicrobial actions.",
author = "V. Rettori and Alejandro Lomniczi and Elverdin, {J. C.} and A. Suburo and A. Faletti and A. Franchi and McCann, {S. M.}",
year = "2000",
language = "English (US)",
volume = "917",
pages = "258--267",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Control of salivary secretion by nitric oxide and its role in neuroimmunomodulation

AU - Rettori, V.

AU - Lomniczi, Alejandro

AU - Elverdin, J. C.

AU - Suburo, A.

AU - Faletti, A.

AU - Franchi, A.

AU - McCann, S. M.

PY - 2000

Y1 - 2000

N2 - In many in vivo systems exposure to endotoxins (LPS) leads to the co-induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which is important to the regulation of the function of different systems during infection. In submandibular glands (SMG) neural (n)NOS is localized in neural terminals and in striated, granular convoluted and excretory ducts, endothelial (e)NOS in vascular endothelium and ducts, and iNOS in macrophages and in tubules and ducts. In normal adult male rats, injection of an inhibitor of NOS decreased the stimulated salivary secretion and a donor of NO potentiated it, indicating that NO exerts a stimulatory role. A single high dose of LPS (5 mg/kg, i.p.) induced an increase in NOS activity measured by the 14C-citrulline method, increased PGE content almost 100% as measured by RIA, and blocked stimulated salivary secretion. The administration of a specific iNOS inhibitor, aminoguanidine (AG), with LPS not only decreased NOS activity but significantly decreased PGE content, indicating that NO triggered the activation of COX-2. LPS increased conversion of labeled arachidonate to prostaglandins (PGs) showing that COX was induced. Since a PGE1 analogue blocked stimulated salivation, the LPS-induced inhibition of salivation is probably due to release of PGs. Therefore, the use of inhibitors of iNOS and COX-2 could be very useful to increase salivation during infection since saliva has antimicrobial actions.

AB - In many in vivo systems exposure to endotoxins (LPS) leads to the co-induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which is important to the regulation of the function of different systems during infection. In submandibular glands (SMG) neural (n)NOS is localized in neural terminals and in striated, granular convoluted and excretory ducts, endothelial (e)NOS in vascular endothelium and ducts, and iNOS in macrophages and in tubules and ducts. In normal adult male rats, injection of an inhibitor of NOS decreased the stimulated salivary secretion and a donor of NO potentiated it, indicating that NO exerts a stimulatory role. A single high dose of LPS (5 mg/kg, i.p.) induced an increase in NOS activity measured by the 14C-citrulline method, increased PGE content almost 100% as measured by RIA, and blocked stimulated salivary secretion. The administration of a specific iNOS inhibitor, aminoguanidine (AG), with LPS not only decreased NOS activity but significantly decreased PGE content, indicating that NO triggered the activation of COX-2. LPS increased conversion of labeled arachidonate to prostaglandins (PGs) showing that COX was induced. Since a PGE1 analogue blocked stimulated salivation, the LPS-induced inhibition of salivation is probably due to release of PGs. Therefore, the use of inhibitors of iNOS and COX-2 could be very useful to increase salivation during infection since saliva has antimicrobial actions.

UR - http://www.scopus.com/inward/record.url?scp=0033664741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033664741&partnerID=8YFLogxK

M3 - Article

C2 - 11268352

AN - SCOPUS:0033664741

VL - 917

SP - 258

EP - 267

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -